Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple teachers-meticulous student: A domain adaptive meta-knowledge distillation model for medical image classification.

Medical physics·2026
Same author

Automated cardiac coverage assessment in cardiovascular magnetic resonance imaging using an explainable recurrent 3D dual-domain convolutional network.

Medical physics·2024
Same author

Brain age gap estimation using attention-based ResNet method for Alzheimer's disease detection.

Brain informatics·2024
Same author

A social image recommendation system based on deep reinforcement learning.

PloS one·2024
Same author

A cascade transformer-based model for 3D dose distribution prediction in head and neck cancer radiotherapy.

Physics in medicine and biology·2024
Same author

A generalised deep meta-learning model for automated quality control of cardiovascular magnetic resonance images.

Computer methods and programs in biomedicine·2023

Related Experiment Video

Updated: Sep 12, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

354

An integrated predictive model for Alzheimer's disease progression from cognitively normal subjects using generated

Atefe Aghaei1, Mohsen Ebrahimi Moghaddam2

  • 1Faculty of Computer Science and Engineering, Shahid Beheshti University, Tehran, Iran.

Scientific Reports
|August 4, 2025
PubMed
Summary

This study introduces a novel AI framework to predict Alzheimer's disease (AD) progression from cognitively normal stages. The method accurately forecasts AD up to 10 years, aiding early diagnosis and intervention.

Keywords:
Alzheimer’s progression predictionAutomatic ROI extractionEnsemble transfer learningMRIProbabilityVit-GAN

More Related Videos

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.2K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.1K

Related Experiment Videos

Last Updated: Sep 12, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

354
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.2K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.1K

Area of Science:

  • Neuroscience
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder with early cognitive changes.
  • Early diagnosis of AD is critical for timely intervention and management.
  • Predicting AD progression from cognitively normal (CN) stages remains a challenge due to limited longitudinal data.

Purpose of the Study:

  • To develop an integrated AI framework for predicting Alzheimer's disease progression from cognitively normal stages.
  • To leverage ensemble transfer learning, generative modeling, and ROI extraction for AD prediction.
  • To enhance model transparency by identifying key brain regions involved in disease progression.

Main Methods:

  • Utilized the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset.
  • Employed a three-stage process: ensemble transfer learning for CN to MCI transition probability estimation, ViT-GANs for simulating future MRI images, and 3D CNN with isotonic regression for AD prediction.
  • Applied Grad-CAM for interpreting critical regions of interest (ROIs).

Main Results:

  • Achieved high accuracy (0.85) and F1-score (0.86) in predicting CN to AD conversion up to 10 years.
  • Successfully generated synthetic MRI images simulating disease progression.
  • Identified key brain regions associated with AD progression through ROI interpretation.

Conclusions:

  • The proposed integrated framework shows significant potential for early Alzheimer's disease diagnosis.
  • The approach addresses data limitations by generating synthetic images and improves interpretability.
  • Offers a promising tool for personalized intervention strategies in Alzheimer's disease management.